AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles

• Published in: Scientific reports Vol. 10; no. 1; p. 19750
• Main Authors: Dai, Xiuliang, Wang, Yufeng, Yang, Haiyan, Gao, Tingting, Yu, Chunmei, Cao, Fang, Xia, Xiyang, Wu, Jun, Zhou, Xianju, Chen, Li
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 12.11.2020; Nature Publishing Group
• Subjects: 692/699/2732/1577; 692/699/2732/2730; 692/700/1750/1747; Adult; Anti-Mullerian Hormone - blood; Embryo transfer; Embryos; Female; Fertilization; Fertilization in Vitro - methods; Follicle-stimulating hormone; Humanities and Social Sciences; Humans; Implantation; Infertility, Female - blood; Infertility, Female - therapy; Live Birth; multidisciplinary; Oocytes; Oocytes - cytology; Oocytes - metabolism; Ovarian Follicle - cytology; Ovarian Follicle - metabolism; Ovaries; Ovulation Induction; Pregnancy; Pregnancy Rate; Retrospective Studies; Science; Science (multidisciplinary); Sperm Injections, Intracytoplasmic - methods

It has been widely acknowledged that anti-Müllerian hormone (AMH) is a golden marker of ovarian reserve. Declined ovarian reserve (DOR), based on experience from reproductive-aged women, refers to both the quantitative and qualitative reduction in oocytes. This view is challenged by a recent study c...